All stock lists
RedHill Biopharma Ltd. (NASDAQ:RDHL)
IL · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
0.43+0.00 (+0.57%)
Market cap
$1.34M
Health Score
Analyst consensus
Listed since
Jan 7, 2013
Website
Insider Score
––Not scored
RDHL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RDHL Stock Insider Trading Activity
RDHL stock’s insider trading shows 2 sales on the open market for an estimated $2.84K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Raday Gilead COO | Sell | 14,310,000 | $0.00 | $1.43K | 7.5% | 176,910,000 | Oct 1, 2026 | — | Form 4 |
| Raday Gilead COO | Sell | 14,130,000 | $0.00 | $1.41K | 6.1% | 218,780,000 | Jul 10, 2026 | — | Form 4 |
| Raday Gilead COO | Sell | 15,740,000 | $0.00 | $1.57K | 5.7% | 261,060,000 | Apr 6, 2026 | — | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.